Alimentary Pharmacology & Therapeutics

Cover image for Vol. 37 Issue 6

March 2013

Volume 37, Issue 6

Pages 587–658

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. Review article: the management of long-term parenteral nutrition (pages 587–603)

      M. Dibb, A. Teubner, V. Theis, J. Shaffer and S. Lal

      Article first published online: 17 JAN 2013 | DOI: 10.1111/apt.12209

  2. RANDOMISED CLINICAL TRIAL

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
      Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study (pages 604–612)

      J. H. Tabibian, E. Weeding, R. A. Jorgensen, J. L. Petz, J. C. Keach, J. A. Talwalkar and K. D. Lindor

      Article first published online: 5 FEB 2013 | DOI: 10.1111/apt.12232

  3. CROHN'S DISEASE

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
      A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease (pages 613–621)

      G. D. Naismith, L. A. Smith, S. J. E. Barry, J. I. Munro, S. Laird, K. Rankin, A. J. Morris, J. W. Winter and D. R. Gaya

      Article first published online: 24 JAN 2013 | DOI: 10.1111/apt.12221

    2. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease (pages 622–629)

      F. L. Cameron, K. Gerasimidis, A. Papangelou, D. Missiou, V. Garrick, T. Cardigan, E. Buchanan, A. R. Barclay, P. McGrogan and R. K. Russell

      Article first published online: 30 JAN 2013 | DOI: 10.1111/apt.12230

  4. NAFLD

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
  5. AUTOIMMUNE HEPATITIS

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis (pages 640–646)

      Y. S. de Boer, N. M. F. van Gerven, N. K. H. de Boer, C. J. J. Mulder, G. Bouma and C. M. J. van Nieuwkerk

      Article first published online: 24 JAN 2013 | DOI: 10.1111/apt.12223

  6. HEPATITIS C

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
      Associations of chronic hepatitis C with metabolic and cardiac outcomes (pages 647–652)

      Z. M. Younossi, M. Stepanova, F. Nader, Z. Younossi and E. Elsheikh

      Article first published online: 5 FEB 2013 | DOI: 10.1111/apt.12234

  7. INVITED COMMENTARY

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
  8. LETTERS TO THE EDITORS

    1. Top of page
    2. REVIEW ARTICLE
    3. RANDOMISED CLINICAL TRIAL
    4. CROHN'S DISEASE
    5. NAFLD
    6. AUTOIMMUNE HEPATITIS
    7. HEPATITIS C
    8. INVITED COMMENTARY
    9. LETTERS TO THE EDITORS
    1. You have free access to this content
      Letter: factors that may predict response to ciclosporin in ulcerative colitis (page 654)

      K. Farkas, A. Bálint, F. Nagy, Z. Szepes, M. Szűcs, T. Wittmann and T. Molnár

      Article first published online: 14 FEB 2013 | DOI: 10.1111/apt.12190

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content

SEARCH

SEARCH BY CITATION